This document provides information about pancreatitis, including:
- Pancreatitis is inflammation of the pancreas that can be acute (presenting as an emergency) or chronic (a prolonged disorder resulting in pancreatic fibrosis).
- The two major causes of acute pancreatitis are gallstones and alcohol abuse. Acute pancreatitis presents with severe abdominal pain and elevated pancreatic enzymes.
- Severe acute pancreatitis is characterized by pancreatic necrosis, systemic inflammatory response, and often multi-organ failure with a mortality rate of 20-50%.
- Chronic pancreatitis is defined as a continuing inflammatory disease of the pancreas causing pain and/or permanent loss of pancreatic function.
Acute and Chronic Pancreatitis- Their Causes, Symptoms and TreatmentsDr. Vikas Singla
Pancreatitis can be of two types: acute and chronic. The only difference between these two types of pancreatitis is that chronic pancreatitis usually lasts for several years but is not so severe like acute pancreatitis.
Before knowing about the treatments that are available for treating pancreatitis, it is essential to know the causes of the pancreatitis disease.
Pancreatitis is an inflammatory condition of the pancreas. Two major forms : acute pancreatitis (is reversible) and chronic pancreatitis(is irreversible).
severe acute pancreatitis has high mortality rate and there is always confusions in between physicians. This topic is about management of acute pancreatitis its complications and ongoing controvercies. hope this will help and clear the doubts among physicians, residents and medical students
Acute and Chronic Pancreatitis- Their Causes, Symptoms and TreatmentsDr. Vikas Singla
Pancreatitis can be of two types: acute and chronic. The only difference between these two types of pancreatitis is that chronic pancreatitis usually lasts for several years but is not so severe like acute pancreatitis.
Before knowing about the treatments that are available for treating pancreatitis, it is essential to know the causes of the pancreatitis disease.
Pancreatitis is an inflammatory condition of the pancreas. Two major forms : acute pancreatitis (is reversible) and chronic pancreatitis(is irreversible).
severe acute pancreatitis has high mortality rate and there is always confusions in between physicians. This topic is about management of acute pancreatitis its complications and ongoing controvercies. hope this will help and clear the doubts among physicians, residents and medical students
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
3. Pancreatitis is inflammation of the gland
parenchyma of the pancrease.
For clinical purposes, it is useful to divide pancreati-
tis into :
Acute, which presents as an emergency, and
Chronic, which is a prolonged and frequently
lifelong disorder resulting from the development of
fibrosis within the pancreas.
It is probable that acute pancreatitis is but a phase of
chronic pancreatitis.
4. Acute pancreatitis is defined as an acute condition presenting
with abdominal pain and is usually associated with raised
pancreatic enzyme levels in the blood or urine as a result of
pancreatic inflammation. Acute pancreatitis may recur.
The underlying mechanism of injury in pancreatitis is thought
to be premature activation of pancreatic enzymes within the
pancreas, leading to a process of autodigestion.
Anything that injures the acinar cell and impairs the
secretion of zymogen granules, or damages the duct
epithelium and thus delays enzymatic secretion, can trigger
acute pancreatitis.
5. Once cellular injury has been initiated, the inflammatory
process can lead to pancreatic oedema, haemorrhage and,
eventually, necrosis.
As inflammatory mediators are released into the
circulation, systemic complications can arise, such as
haemodynamic instability, bacteraemia (due to
translocation of gut flora), acute respiratory distress
syndrome and pleural effusions, gastrointestinal
haemorrhage, renal failure and disseminated intravascular
coagulation (DIC).
6. Acute pancreatitis may be categorised as mild or severe.
Mild acute pancreatitis is characterised by interstitial
oedema of the gland and minimal organ dysfunction. Eighty
per cent of patients will have a mild attack of pancreatitis, the
mortality from which is around 1%.
Severe acute pancreatitis is characterised by
pancreatic necrosis, a severe systemic inflammatory response
and often multi-organ failure, the mortality varies from 20% to
50%.
About one-third of deaths occur in the early phase of the
attack, from multiple organ failure, while deaths occurring
after the first week of onset are due to septic complications.
7. Chronic pancreatitis is defined as a continuing
inflammatory disease of the pancreas characterised by
irreversible morphological change typically causing pain
and/or permanent loss of function. Many patients with
chronic pancreatitis have exacerbations, but the
condition may be completely painless.
8. Incidence
Acute pancreatitis accounts for 3% of all cases of
abdominal pain among patients admitted to hospital in the
UK.
The hospital admission rate for acute pancreatitis is 9.8 per
year per 100 000 population in the UK, although worldwide,
the annual incidence may range from 5 to 50 per 100 000.
The disease may occur at any age, with a peak in young
men and old women.
9. Etiology
The two major causes of acute pancreatitis
Biliary calculi, which occur in 50–70% of
patients, and
Alcohol abuse, which accounts for 25% of
cases.
10. Gallstone pancreatitis: is thought to be triggered
by the passage of gallstones down the common bile
duct.
If the biliary and pancreatic ducts join to share a
common channel before ending at the ampulla, then
obstruction of this passage may lead to reflux of bile
or activated pancreatic enzymes into the pancreatic
duct.
Patients who have small gallstones and a wide cystic
duct may be at a higher risk of passing stones.
12. Alcoholic pancreatitis
The proposed mechanisms for alcoholic
pancreatitis include the effects of diet,
malnutrition, direct toxicity of alcohol,
concomitant tobacco smoking,
hypersecretion, duct obstruction or reflux,
and hyperlipidaemia.
13. Possible causes of acute pancreatitis
Gallstones
Alcoholism
Post ERCP
Abdominal trauma
Following biliary, upper gastrointestinal
or cardiothoracic surgery
Ampullary tumour
15. ■ It is essential to establish the aetiology
■ Investigate thoroughly before labelling
it as ‘idiopathic’
■ After the acute episode resolves,
remember further management of the
underlying aetiology
■ If the aetiology is gallstones,
cholecystectomy is desirable during the
same admission
16. Clinical presentation
Pain is the cardinal symptom.
It characteristically develops quickly, reaching
maximum intensity within minutes rather than
hours and persists for hours or even days.
The pain is frequently severe,constant and
refractory to the usual doses of analgesics.
17. Pain is usually experienced first in the epigastrium but
may be localised to either upper quadrant or felt diffusely
throughout the abdomen.
There is radiation to the back in about 50% of patients,
and some patients may gain relief by sitting or leaning
forwards.
The suddenness of onset may simulate a perforated
peptic ulcer, while biliary colic or acute cholecystitis can
be mimicked if the pain is maximal in the right upper
quadrant.
18. Radiation to the chest can simulate myocardial
infarction, pneumonia or pleuritic pain.
In fact, acute pancreatitis can mimic most causes of
the acute abdomen and should seldom be discounted in
differential diagnosis.
19. Nausea, repeated vomiting and retching are usually marked
accompaniments. The retching may persist despite the
stomach being kept empty by nasogastric aspiration.
Hiccoughs can be troublesome and may be due to gastric
distension or irritation of the diaphragm.
20. On examination, the appearance may be that of a
patient who with profound shock, toxicity and
confusion.
Tachypnoea is common,
Tachycardia is usual,
Hypotension may be present.
The body temperature is often normal or even
subnormal, but frequently rises as inflammation
develops.
Mild icterus can be caused by biliary obstruction in
gallstone pancreatitis, and an acute swinging pyrexia
suggests cholangitis.
21. Bleeding into the fascial planes can produce bluish
discolouration of the flanks (Grey Turner’s sign) or
umbilicus (Cullen’s sign). Neither sign is
pathognomonic of acute pancreatitis; Cullen’s sign was
first described in association with rupture of an ectopic
pregnancy.
Subcutaneous fat necrosis may produce small, red,
tender nodules on the skin of the legs.
Abdominal examination may reveal distension due to
ileus or, more rarely, ascites with shifting dullness.
22. A mass can develop in the epigastrium due to
inflammation.
There is usually muscle guarding in the upper abdomen,
although marked rigidity is unusual.
A pleural effusion is present in 10–20% of patients.
Pulmonary oedema and pneumonitis are also described and
may give rise to the differential diagnosis of pneumonia or
myocardial infarction.
The patient may be confused and exhibit the signs of
metabolic derangement together with hypoxaemia.
23. Investigations
Typically, the diagnosis is made on the basis
of the clinical presentation and an elevated
serum amylase level.
A serum amylase level three to four times
above normal is indicative of the disease.
A normal serum amylase level does not
exclude acute pancreatitis, particularly if the
patient has presented a few days later.
24. If the serum lipase level can be checked, it provides a
slightly more sensitive and specific test than amylase.
If there is doubt, and other causes of acute abdomen have
to be excluded, contrast-enhanced CT is probably the best
single imaging investigation.
Investigations in acute pancreatitis should be aimed
at answering three questions:
■ Is a diagnosis of acute pancreatitis correct?
■ How severe is the attack?
■ What is the aetiology?
25. Assessment of severity
Various scoring systems,
Ranson
Glasgow scoring systems
The APACHE II scoring system, used in
intensive care units, can also be applied.
26.
27. Sever attack may be heralded by an initial clinical
impression of a very ill patient and an APACHE II score
above 8. At 48 hours after the onset of symptoms,
Glasgow score of 3 or more, a C-reactive protein level
greater than 150 mg l–1 and a worsening clinical state with
sepsis or persisting organ failure indicate a severe attack.
Severity stratification should be performed in all patients
within 48 hours of diagnosis.
Patients with a body mass index over 30 are at higher risk
of developing complications.
28. Acute Severe Pancreatitis
Pathophysiology
Injury or disruption of pancreatic ducts
leakage of pancreatic enzymes autodigestion
Breakdown of cell membranes edema
vascular damage, hemorrhage, necrosis
inflammatory mediators Shock, MODS, …..
29. Imaging
Plain erect chest and abdominal radiographs are not
diagnostic of acute pancreatitis, but are useful in the
differential diagnosis.
Non-specific findings in pancreatitis include a generalised or
local ileus (sentinel loop), a colon cut-off sign and a renal
halo sign. Occasionally, calcified gallstones or pancreatic
calcification may be seen
A chest radiograph may show a pleural effusion and, in
severe cases, a diffuse alveolar interstitial shadowing may
suggest acute respiratory distress syndrome.
30. Ultrasound does not establish a diagnosis of acute
pancreatitis. The swollen pancreas may be seen, but
ultrasonography should be performed within 24 hours in all
patients to detect gallstones as a potential cause, rule out
acute cholecystitis as a differential diagnosis and determine
whether the common bile duct is dilated.
31. CT is not necessary for all patients, particularly those
deemed to have a mild attack on prognostic criteria. But
a contrastenhanced CT is indicated in the following
situations:
• if there is diagnostic uncertainty;
• in patients with severe acute pancreatitis, to distinguish
interstitial from necrotising pancreatitis.
In the first 72 hours, CT may underestimate the extent
of necrosis.
The severity of pancreatitis detected on CT may be
staged according to the Balthazar criteria;
32. • in patients with organ failure, signs of sepsis or
progressive clinical deterioration;
• when a localised complication is suspected, such as fluid
collection, pseudocyst or a pseudoaneurysm.
Cross-sectional MRI can yield similar information to that
obtained by CT.
EUS and MRCP can help in detecting stones in the
common bile duct and directly assessing the pancreatic
parenchyma.
ERCP allows the identification and removal of stones in the
common bile duct in gallstone pancreatitis.
33. The presentation is so variable that sometimes even an expe-
rienced clinician can be mistaken, occasionally the diagnosis is
only made at laparotomy. The appearances at laparotomy are
characteristic
34. Key Questions
What clinical manifestation occurs because the
pancreas lies retroperitoneally in the abdominal
cavity?
What is the sphincter of Oddi? What common pain
medication causes spasms of this sphinter?
Which digestive enzymes are secreted by the
pancreas?
What is the hallmark lab abnormality in pancreatitis?
35. Assessment
Physiological Variable
Diagnostic tests
Serum amylase
>200U/L for 24-72 hr – 4x
starts to rise 2-6 hr after onset of pain
Peaks @ 24 hours
Return to normal @ 72 hr
Serum lipase
used with amylase; rises later than
amylase (48 hours)
return to normal 5-7 days
WBC’s
glucose
lipids
calcium
magnesium
36. Ranson-Imrie Scale
On admission or dx
Age >55 years
WBC >16K/mm³
BG >200 mg/dl
LDH >400 IU/L
AST >250 IU/L
During first 48 hours
in HCT by 10%
FV or 4000 ml
Ca < 8 mg/dl
PO2 < 60 mm Hg
BUN > 5 mg/dl after IV’s
Serum albumin < 3.2 gm/dl
40. Local (Usually develop after the first week)
Acute fluid collection
Sterile pancreatic necrosis
Infected pancreatic necrosis
Pancreatic abscess
Pseudocyst
Pancreatic ascites
Pleural effusion
Portal/splenic vein thrombosis
Pseudoaneurysm
41. Pulmonary
Enzyme induced inflammation
of the diaphragm
Abdominal distention &
diaphramatic movement
Pleural Effusion
Atelectasis
Pancreatic enzymes can injure the lungs directly
Watch for hypoxia – PO 2 < 60 mm Hg
43. - Cardiovascular Complications
3rd spacing BP, HR, vasoconstriction
(compensatory mechanisms) d/t SNS activation
Recall: compensatory mechanisms work for only a
short while before they begin to fail
45. Renal
Hypovolemia GFR, renal perfusion
development of clots in renal circulation
Acute tubular necrosis & Acute renal failure
46. Immunological
GI motility movement of bacteria outside GI tract
pancreatic abscesses & necrosis INFECTION
47. If mild attack of pancreatitis, a conservative approach is
indicated with intravenous fluid administration and frequent,
but non-invasive, observation.
A brief period of fasting may be sensible in a patient who is
nauseated and in pain, but there is little physiological
justification for keeping patients on a prolonged ‘nil by mouth’
regimen.
Antibiotics are not indicated.
Apart from analgesics and anti-emetics, no drugs or
interventions are warranted.
CT scanning is unnecessary unless there is evidence of
deterioration.
48. Severe attack of pancreatitis, a more aggressive approach is
required,
Patients should be admitted to an intensive care or high-
dependency unit
Adequate analgesia should be administered.
Aggressive fluid resuscitation guided by frequent measurement
of vital signs, urine output and central venous pressure.
Supplemental oxygen administered and serial arterial blood
gas analysis performed.
The haematocrit, clotting profile, blood glucose and serum
levels of calcium and magnesium should be closely monitored.
49. A nasogastric tube is not essential but may be of value in
patients with vomiting.
Specific treatments such as aprotinin,somatostatin
analogues, platelet-activating factor inhibitors and
selective gut decontamination have failed to improve
outcome in numerous clinical trials and should not be given.
There are no data to support a practice of ‘resting’ the
pancreas and feeding only by the parenteral or nasojejunal
routes.
If nutritional support is felt to be necessary, enteral nutrition
(e.g. feeding via a nasogastric tube) is should be used
50. There is some evidence to support the use of
prophylactic antibiotics (intravenous cefuroxime, or
imipenem, or ciprofloxacin plus metronidazole) in
patients with severe acute pancreatitis for the
prevention of local and other septic complications.
The duration of antibiotic prophylaxis should not exceed
14 days.
Additional antibiotic use should be guided by
microbiological cultures.
51. If gallstones are the cause of an attack of predicted or proven
severe pancreatitis, or if the patient has jaundice, cholangitis
or a dilated common bile duct, urgent ERCP should be carried
out within 72 hours of the onset of symptoms.
There is evidence that sphincterotomy and clearance of the
bile duct can reduce the incidence of infective complications in
these patients.
In patients with cholangitis, sphincterotomy should be carried
out or a biliary stent placed to drain the duct.
52. Early management of severe acute pancreatitis
Admission to HDU/ICU
Analgesia
Aggressive fluid rehydration
Oxygenation
Invasive monitoring of vital signs, central venous pressure,
urine output, blood gases
Frequent monitoring of haematological and biochemical
parameters (including liver and renal function, clotting,
serum calcium, blood
glucose)
53. Nasogastric drainage
Antibiotic prophylaxis can be considered (imipenem,
cefuroxime)
CT scan essential if organ failure, clinical deterioration or signs
of sepsis develop
ERCP within 72 hours for severe gallstone pancreatitis or signs
of cholangitis
Supportive therapy for organ failure if it develops (inotropes,
ventilatory support, haemofiltration, etc.)
If nutritional support is required, consider enteral
(nasogastric) feeding
54. Collaborative Management –
Pain
“Rest” the pancreas & GI tract
NPO
NG tube to suction
parenteral vs. enteral nutrition
drug therapy
Manage Pain
morphine
H2 antagonists
PPI’s
Acute Pain r/t inflammation of pancreas and surrounding
tissue, obstuction of biliary tree & interruption of blood
supply to pancreatic tissue
56. Collaborative Management
Hemodynamic stability
Fluid volume replacement
crystalloid, colloid or blood products
Hemodynamic monitoring (CVP or PA)
Monitor peripheral circulation, UOP
Risk for fluid imbalance r/t vomiting & intake, fever &
diaphoresis, fluid shifts, N/G suction
Vasoactive drugs – dopamine
BP via vasoconstriction in high doses
renal perfusion in lower doses
57. Collaborative Management
Respiratory Care
Supplemental O2 @ 4l/NC
Positioning for adequate ventilation
Cough, deep breathe, IS with pain control
Monitor ABG’s, respiratory effort & breath sounds
Ineffective Breathing Pattern r/t abdominal distention,
ascites, pain or respiratory compromise
58. Collaborative Management
Maintain Metabolic Balance
Monitor labs for alterations, report significant alterations.
Risk for Fluid Imbalance r/t (same as previous dx)
K, Ca dysrhythmias
Ca neurologic changes
FBS hyperosmolar diuresis, electrolyte shifts
BUN, Creatinine indicates renal damage from perfusion
Amylase, lipase for return to normal
59. Collaborative Management-
Alcohol Withdrawal Syndrome
Monitor for withdrawal from alcohol
Clinical manifestations of hyperactive sympathetic
nervous system
body temperature & VS
Diaphoresis
Anxiety/Aggitation
Tremors/Shakiness